1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The Surprise Question and Health-Related Quality of Life in Patients on Hemodialysis : A Cross-Sectional Multicenter Study
(
- Contribution to journal › Article
- 2023
-
Mark
Discrepancy in responses to the surprise question between hemodialysis nurses and physicians, with focus on patient clinical characteristics : A comparative study
(
- Contribution to journal › Article
- 2020
-
Mark
Processes toward the end of life and dialysis withdrawal Physicians’ and nurses’ perspectives
(
- Contribution to journal › Article
- 2019
-
Mark
End-of-life and palliative care of patients on maintenance hemodialysis treatment : a focus group study
(
- Contribution to journal › Article
- 2018
-
Mark
Unmet Palliative Care Needs Among Patients With End-Stage Kidney Disease : A National Registry Study About the Last Week of Life
(
- Contribution to journal › Article
- 2015
-
Mark
Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
(
- Contribution to journal › Article
- 2014
-
Mark
Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
(
- Contribution to journal › Article
- 2013
-
Mark
WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells
(
- Contribution to journal › Article
- 2010
-
Mark
Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
(
- Contribution to journal › Article